skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.06d (Release date: 2017-06-26)
SearchBox Top
SearchBox Bottom
MAGE-A3 Peptide Vaccine (Code C91710)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: MAGE-A3 Peptide Vaccine

Definition: A peptide cancer vaccine comprised of a peptide derived from the human melanoma antigen A3 (MAGE-A3), with potential immunostimulating and antineoplastic activities. Upon administration, MAGE-A3 peptide vaccine may stimulate the immune system to mount a cytotoxic T-cell (CTL) response against tumor cells expressing MAGE-A3, resulting in tumor cell lysis. MAGE-A3, a tumor-associated antigen (TAA), is overexpressed by a variety of cancer cell types.

Display Name: MAGE-A3 Peptide Vaccine

Label: MAGE-A3 Peptide Vaccine

NCI Thesaurus Code: C91710 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: C1541478  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
MAGE-A3 Peptide Vaccine

External Source Codes: 
PDQ Closed Trial Search ID 391278
PDQ Open Trial Search ID 391278 (check for NCI PDQ open clinical trial info)
UMLS CUI C1541478

Other Properties:
     Name Value (qualifiers indented underneath)
code C91710
Contributing_Source CTRP
Semantic_Type Amino Acid, Peptide, or Protein
Semantic_Type Pharmacologic Substance

Additional Concept Data: 
Defined Fully by Roles: No  


Mainbox Bottom